Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · Real-Time Price · USD
1.070
+0.040 (3.88%)
At close: Jun 5, 2026, 4:00 PM EDT
0.9505
-0.1200 (-11.17%)
After-hours: Jun 5, 2026, 7:59 PM EDT

Arcadia Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2384723
Market Cap Growth
-60.70%-66.35%100.85%-39.76%-71.05%-32.20%
Enterprise Value
-1.52-1.843.84-7.6-13.09-3.29
Last Close Price
1.071.985.923.1310.8441.60
PS Ratio
0.460.561.600.900.903.40
PB Ratio
0.760.661.300.310.320.74
P/TBV Ratio
0.570.651.300.300.310.71
EV/Sales Ratio
--0.380.76-1.71-1.76-0.49
EV/EBITDA Ratio
-0.79-1.491.040.10
EV/EBIT Ratio
-0.74-1.250.930.09
EV/FCF Ratio
-0.39-0.500.930.12
Debt / Equity Ratio
-000.010.050.07
Net Debt / Equity Ratio
-1.29-1.10-0.66-0.83-0.89-0.82
Net Debt / EBITDA Ratio
1.251.951.422.081.470.77
Net Debt / FCF Ratio
0.880.960.420.701.330.95
Asset Turnover
0.800.480.300.180.200.15
Inventory Turnover
3.042.933.401.381.812.11
Quick Ratio
3.042.422.113.385.195.96
Current Ratio
3.793.093.614.176.037.02
Return on Equity (ROE)
-243.02%-45.14%-45.62%-83.24%-59.94%-54.01%
Return on Assets (ROA)
-51.02%-25.01%-22.00%-25.13%-38.51%-77.86%
Return on Invested Capital (ROIC)
-630.18%-65.78%-53.83%-103.26%-164.83%-241.24%
Return on Capital Employed (ROCE)
-71.71%-32.38%-26.95%-29.89%-44.05%-88.91%
Buyback Yield / Dilution
-13.40%-0.35%-10.22%-106.37%-12.66%-113.68%
Total Shareholder Return
-13.40%-0.35%-10.22%-106.37%-12.66%-113.68%
SEC Filings: 10-K · 10-Q